Last Updated: June 22, 2026

LEUCOVORIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Leucovorin patents expire, and what generic alternatives are available?

Leucovorin is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Gland, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Fresenius Kabi Usa, Ingenus Pharms Llc, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, Xanodyne Pharm, Am Regent, Mylan Labs Ltd, Sagent Pharms, and Sagent Pharms Inc. and is included in forty-nine NDAs.

The generic ingredient in LEUCOVORIN is leucovorin calcium. There are nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Leucovorin

A generic version of LEUCOVORIN was approved as leucovorin calcium by HIKMA on September 14th, 1987.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for LEUCOVORIN?
  • What are the global sales for LEUCOVORIN?
  • What is Average Wholesale Price for LEUCOVORIN?
Summary for LEUCOVORIN
US Patents:0
Applicants:24
NDAs:49
Drug Prices: Drug price information for LEUCOVORIN
DailyMed Link:LEUCOVORIN at DailyMed

US Patents and Regulatory Information for LEUCOVORIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium SOLUTION;INTRAMUSCULAR, INTRAVENOUS 040347-001 Apr 25, 2000 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 072734-001 Feb 22, 1993 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Ingenus Pharms Llc LEUCOVORIN CALCIUM leucovorin calcium SOLUTION;INTRAMUSCULAR, INTRAVENOUS 210917-001 Nov 23, 2018 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Leading LEUCOVORIN CALCIUM leucovorin calcium TABLET;ORAL 213929-002 Oct 22, 2020 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Fresenius Kabi Usa LEUCOVORIN CALCIUM PRESERVATIVE FREE leucovorin calcium INJECTABLE;INJECTION 040258-001 Feb 26, 1999 AP RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.